Cartesian Therapeutics Inc. (RNAC) financials · rev $2.8M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Cartesian Therapeutics Inc. (RNAC) rev $2.8M.
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | $2.80M | $38.91M | |
| Operating Income | −$143.41M | −$43.90M | |
| Net Income | −$130.30M | −$77.42M | |
| EPS (Diluted) | −$5.02 | −$4.49 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $296.41M | $435.02M | |
| Current Assets | $129.28M | $216.63M | |
| Cash & Equivalents | $125.14M | $212.61M | |
| PP&E | $12.19M | $9.91M | |
| Total Liabilities | $422.65M | $441.82M | |
| Current Liabilities | $14.94M | $22.98M | |
| Long-term Debt | — | — | |
| Shareholders' Equity | −$126.24M | −$6.80M | |
| Retained Earnings | −$822.37M | −$692.07M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$73.94M | −$23.67M | |
| CapEx | $5.45M | $9.09M | |
| Investing Cash Flow | −$5.45M | −$8.74M | |
| Financing Cash Flow | −$8.05M | $168.43M | |
| Net Change in Cash | −$87.41M | $135.99M | |
| Free Cash Flow | −$79.39M | −$32.77M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is RNAC P/E and revenue?
Cartesian Therapeutics Inc. (RNAC) rev $2.8M.
What is RNAC revenue?
Cartesian Therapeutics Inc. last cached revenue is $2.80M (FY2025).
Is RNAC profitable?
Cartesian Therapeutics Inc. last cached net income is -$130.3M (FY2025).
What are RNAC total assets?
Cartesian Therapeutics Inc. last cached total assets are $296.4M (FY2025).
What is RNAC free cash flow?
Cartesian Therapeutics Inc. last cached free cash flow is -$79.4M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.